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ABSTRACT  1 
Objective:  Developmentally sensitive measures of vision-related quality of life (VQoL) are 2 
needed to capture age-specific concerns about the impact of living with visual impairment 3 
(VI) in children and young people. Our objective was to use our validated vision-related 4 
quality of life instrument for children and young people aged 10-15 years (the VQoL_CYP) as 5 
the foundation for development of age-specific extensions.  6 
Design: Questionnaire development 7 
Participants: A representative sample of children and young people aged 6-19 years with 8 
visual impairment, visual acuity of the logarithm of the minimum angle of resolution 9 
(LogMAR) worse than 0.50 in the better eye. They were identified and recruited from 10 
Paediatric Ophthalmology clinics at Great Ormond Street Hospital and Moorfields Eye 11 
Hospital and in the final phase of the study from 20 further UK hospitals. 12 
Methods: Standard instrument development processes were followed across four phases. 13 
29 semi-structured interviews with children and young people permitted draft age-appropriate 14 
instrument extensions. 28 cognitive interviews informed age-appropriate items and response 15 
options. Age-appropriate instrument extensions were pre-piloted on 49 subjects to ensure 16 
feasibility, and administered via a postal survey to a national sample of 160 for psychometric 17 
evaluation using Rasch analysis. Construct validity was evaluated through correlations with 18 
the Pediatric Quality of Life Inventory (PedsQL).  19 
Main Outcome measures: Psychometric indices of validity and reliability of the instrument 20 
versions. 21 
Results: Interviews confirmed the existing VQoL_CYP content and format were relevant 22 
across a wider age-range. Age-appropriate extensions were drafted for children (8-12 years) 23 
and young people (13-17 years). Psychometric item reduction produced 20-item child and 24 
22-item young person versions, each with acceptable fit values, no notable differential item 25 
3 
functioning, good measurement precision, ordered response categories and acceptable 26 
targeting, and no notable differential item functioning on items common to both. Construct 27 
validity was demonstrated through correlations with health-related quality of life (r = .71).  28 
Conclusions: Using an efficient child/young person-centred approach we have developed 29 
two robust, age-appropriate versions of an instrument capturing VQoL that can be used 30 
cross-sectionally or sequentially across the age-range of 8-17 years in research and clinical 31 




The use of patient-reported outcomes measures (PROMs) is now well established in both 33 
clinical practice and in research evaluating new treatments.1 PROMs enabling self-report of 34 
health-related quality of life (HRQoL), which cannot be captured through objective clinical 35 
assessments, are particularly important. Generic HRQoL measures2,3 designed with 36 
developmental differences in mind, have followed the standard approach of concurrent 37 
development of age-appropriate instrument versions across different age groups, by drawing 38 
on the whole population. This approach is challenging in populations with rare ophthalmic 39 
disorders such as those causing visual impairment or blindness (VI for brevity throughout). 40 
Visually impairing disorders collectively affect about 2 per 1000 children and young people in 41 
industrialised countries.4,5 Most children and young people with VI are affected from infancy. 42 
All will face significant lifelong challenges through the impact on development, education, 43 
social and emotional wellbeing alongside high economic costs for affected individuals, their 44 
families and society.6 In the industrialised world and increasingly in developing countries, 45 
most affected individuals have disorders that are currently neither preventable nor curable. 46 
There is therefore a strong focus on maintaining residual vision and functional abilities in 47 
order to maximise vision-related quality of life (VQoL). However reliable and valid measures 48 
of VQoL in children and young people remain scarce, partly due to the challenges of 49 
research on populations with rare disorders.7 Hitherto, most PROMs for children and young 50 
people with ophthalmic conditions, including those designed to assess VQoL, comprise 51 
either a single instrument used across a very wide age-range8,9 or age-specific versions 52 
without age-appropriate items or response formats.10 Thus, they do not take account of the 53 
development of children’s understanding of illness, health and quality of life (QoL) and how 54 
this changes as they mature,11 and cannot capture developmental differences or age-specific 55 
needs in terms of content, response options and ability to complete independently. Our 56 
decision to set the minimum age threshold at 8 years reflects the age from which self-report 57 




We recently reported the first stage psychometric validation of a 35-item instrument 59 
measuring self-reported VQoL in children and young people with VI aged 10-15 years - the 60 
VQoL_CYP.13,14 To ensure content validity, we undertook semi-structured and cognitive 61 
debriefing interviews. In the absence of both an existing conceptual framework and an 62 
established methodology for developing measures for this numerically small population, we 63 
deliberately targeted the 10-15 years age-group in this foundation research, as most capable 64 
of identifying the impact of living with VI through individual interviews and self-completing the 65 
instrument with ease. We now report our planned extension and adaption of that foundation 66 
instrument13,14 to a broader age-range, including our novel approach of calibrating the new 67 
age-appropriate versions so that they can be used and compared in different age-groups at 68 
any given point but also be used to follow subjects over time as they grow older i.e. 69 
sequentially. 70 
METHODS 71 
The study was approved by the National Health Service (NHS) Research Ethics Committee 72 
for Essex and East of England, United Kingdom (UK) and followed tenets of the Declaration 73 
of Helsinki. Participants gave informed individual assent (if <16 years) or consent and 74 
parents gave informed consent to their child’s participation (if <16 years). 75 
Sample 76 
Children and young people were eligible if they were i) visually impaired, severely 77 
visually impaired or blind (visual acuity in the better eye of LogMAR 0.50 or worse or Snellen 78 
worse than 6/18 or additional visual defects causing visual impairment) due to any visual 79 
disorder, but without any other significant impairment (i.e., learning, sensory or motor); and ii) 80 
aged 6-19 years (with age boundaries for the instrument determined later). They were drawn 81 
from 2 patient populations between September 2014 and May 2017 comprising those 82 
attending the Department of Ophthalmology at GOSH and the Pediatric Glaucoma Service 83 




(final phase only) by patients attending 20 other hospitals across Britain (see 85 
Acknowledgments). By sampling across multiple sources nationally in the final phases, 86 
where largest samples are needed, we ensured our sample was as representative as 87 
possible of the UK population of children and young people with VI with respect to ethnic and 88 
socio-economic status. 89 
Procedures 90 
Instrument adaptation followed standard instrument development phases, with our 91 
‘foundation’ research with 10-15 year olds13,14 as the framework.   92 
Phase 1: Item development and adaptation 93 
To investigate whether the issues covered by the existing VQoL_CYP items (from the 10-15 94 
year olds’ instrument13,14) were relevant to children/young people outside the age-range of 95 
10-15 years and identify any new age-specific issues not already included, we conducted 96 
individual in-depth semi-structured interviews with children younger than 10 and young 97 
people older than 15 years. Building on the foundation of the existing VQoL_CYP instrument, 98 
which was based on 32 interviews with 10-15 year olds, we reached data saturation after 29 99 
interviews (12 with children aged 6-9 years, 17 with young people aged 16-19 years). 100 
Interviews were transcribed and coded using NVivo10.15 We used the thematic framework 101 
developed through qualitative thematic analysis in the foundation study that produced the 102 
existing VQoL_CYP instrument for 10-15 year olds, to identify areas of overlap and 103 
discrepancy between the new interview data and the existing instrument. Where omissions 104 
were identified, new, age-appropriate items were developed. 105 
Additionally, to ensure that the subsequent first draft version of the instrument version for 106 
younger children was developmentally appropriate, participants <10 years were asked to 107 
complete the existing VQoL_CYP (10-15 years)13,14 with parental assistance and provide 108 




considered necessary for participants older than 15 years, who were developmentally well 110 
placed to comprehend the existing VQoL_CYP (10-15 years) items.  111 
Phase 2: Pre-testing 112 
The upper and lower age boundaries of each new age-appropriate VQoL instrument version 113 
were developed empirically throughout Phase 2, whilst considering data also from the early 114 
interview phases of the VQoL_CYP (10-15 years) development.13 Due to the extensive 115 
foundation work in development of the original instrument for 10-15 year olds and the 116 
resemblance of the new age-appropriate drafts to the published instrument, recruitment in 117 
this phase was focused primarily on participants younger than 10 and older than 15 years. 118 
Individual cognitive interviews with 12 children aged 7-10 years and 16 young people aged 119 
13-18 years ensured comprehensibility of the new age-appropriate draft instrument versions. 120 
This was supplemented by parental feedback on the same items presented to children and 121 
young people and study group consensus. Items were refined accounting for importance, 122 
comprehensibility, difficulty and response format. Alongside re-reading of the original 123 
individual interviews with 10-15 year olds,13 feedback from children and young people, their 124 
parents, and study group consensus was used to determine the age thresholds for the new 125 
instrument versions as 8-12 years (VQoL_Child) and 13-17 years (VQoL_Young Person). 126 
Phase 3: Pre-piloting 127 
Pre-piloting of the modified new instrument versions comprised a postal survey of 26 children 128 
aged 8-12 years and 23 young people 13-17 years, to ensure feasibility with respect to 129 
missing data and administration burden and to inform initial decisions about subsequent item 130 
reduction. 131 
Participants received a pack comprising invitation letters, child and parent information sheets 132 
and consent/assent forms, the age-appropriate instrument versions in large print (including a 133 




materials. Participants were invited to provide written qualitative feedback. Questionnaire 135 
data were verified by checking the study database, with no errors detected. 136 
Phase 4: Piloting 137 
Formal piloting comprised a large-scale postal survey of a national sample (UK) of 87 138 
children aged 8-12 years and 73 young people aged 13-17 years to confirm psychometric 139 
properties of the two new instrument versions. The VQoL_Child and the VQoL_Young 140 
Person were administered alongside the Child (8-12 years) and Teenager (13-18 years) 141 
versions of the Pediatric Quality of Life Inventory (PedsQL3) to assess construct validity. The 142 
PedsQL, a validated generic HRQoL instrument, produces Total, Physical Health and 143 
Psychosocial Health Scores, with higher scores indicating better HRQoL.3,16  144 
Participants received study packs as per previous phases. Questionnaire data were verified 145 
through double-checking the study database and any data-entry errors corrected. 146 
Psychometric evaluation 147 
In keeping with published criteria,17 data from participants with >25% of item responses 148 
missing were excluded, as were items for which >50% of participant responses were 149 
missing.   150 
Rasch analysis18-22 was used for item reduction and psychometric assessment using 151 
Andrich’s Rasch Rating Scale model.23 Several criteria were used to assess the 152 
appropriateness of the two instruments,17,24 as detailed in Table 2 and Figures 1 and 2. Prior 153 
to conducting Rasch analysis negatively worded items were reversed and 1-4 responses 154 
coded into 0-3 scores.  155 
Calibration of VQoL_Child and VQoL_Young Person.   156 
The model resulting from equating both instruments, as outlined by Lincacre25 ensured that 157 
the age-appropriate instrument versions were capable of measuring the same construct in 158 




dependent instruments provides continuity of measurement for ages 8 to 17 years, ensuring 160 
the instruments can be used in cross-sectional studies. It also allows comparisons of 161 
summary scores measured during follow-up of individuals as they grow older (i.e. sequential 162 
use). These scores are obtained as the sum of all individual item raw scores, and can be 163 
transformed into a Rasch person measures using Table 5 (available at www.aaojournal.org). 164 
This transformation assumes that all items have equal importance, and that response 165 
categories are scaled accordingly to yield an equal value with uniform increments between 166 
consecutive categories. To examine whether the equated Rasch person measures from the 167 
two age groups (8-12 and 13-17 years) were comparable in this way, a final differential item 168 
functioning (DIF) analysis was conducted using the ‘core’ set of items common to both.26  169 
Unidimensionality was assessed using infit and outfit statistics, and the criteria described in 170 
Table 2.17 DIF statistics, shown in Table 2 represent the effect size, in logits of the difference 171 
between the two classifications of persons.27 172 
Construct validity  173 
VQoL summary scores were calculated and converted into Rasch person measures ranging 174 
from 0 (severely reduced VQoL) to 100 (excellent VQoL) using the score-to-measure tables 175 
for each age-appropriate version (Table 5, available at www.aaojournal.org), ensuring the 176 
derived measures can be compared between age-appropriate versions despite differences in 177 
the number and wording of items.  178 
Construct validity (i.e. instrument’s ability to truly measure an intended outcome) was 179 
assessed through correlations between Rasch person measures on the VQoL_Child and 180 
VQoL_Young Person and scores on the Child and Teen PedsQL (Total and Psychosocial 181 
subscale summaries). Participants with any missing responses were excluded from the 182 
analyses. Additionally correlation between Rasch person measures on the VQoL_Child and 183 
VQoL_Young Person and visual acuity was examined, without anticipation of a correlation, in 184 




Correlations with PedsQL were examined using the Rasch person measures for each new 186 
VQoL version individually, before combining scores from both age-appropriate versions. 187 
Spearman’s Rank correlations were reported.  188 
Rasch analysis was conducted using Winsteps, 4.0.1.29 All other analyses were completed 189 
using SPSS.  190 
RESULTS 191 
Table 1 shows the participant characteristics across the study phases, illustrating an 192 
unbiased representation of the overall UK population of children and young people with VI 193 
with respect to clinical and socio-demographic characteristics and ophthalmic diagnoses 194 
(given the exclusion of participants with any other significant impairment).5,13,14  195 
Phase 1: Item development and adaptation 196 
Analysis of the new interview data revealed significant overlap between the issues raised by 197 
children younger than 10 and young people older than 15 years, and the issues covered by 198 
the existing VQoL_CYP instrument for 10-15 year olds.13,14 Where age-related variation 199 
emerged it was in descriptions/and attributions of issues to QoL, rather than differences in 200 
the type of issues experienced, necessitating some adaptations. For the older age group, 11 201 
items removed during the foundation research were reinstated based on views expressed in 202 
the interviews regarding relevance. A new item on tiredness and impact on sleep, as flagged 203 
by participants, was added.  204 
The format involving the illustrative child/3rd person vignette was changed as a result of 205 
significant skew in VQoL_CYP items presented on the ‘ideal status’ scale in the foundation 206 
study.14 All items were re-worded as first person statements (e.g. ‘I feel left out because of 207 
my eyesight’) and response categories amended accordingly whereby the responding 208 
child/young person reported how true each statement was about him/her. Four response 209 




vocabulary used during interviews (1-Not at all true, 2-A little bit true, 3-Mostly true, 4-211 
Completely true). 212 
The resulting draft 31-item VQoL_Child and 37-item VQoL_Young Person versions for 213 
children aged <10 years and young people aged >15 years, were pre-tested.  214 
Phase 2: Pre-testing 215 
A small number of items considered ambiguous by participants were re-phrased or removed. 216 
The minimum age threshold was agreed as 8 years and age boundaries re-adjusted as 8-12 217 
years and 13-17 years, thus aligning to other child PROMs.3 The resulting 29-item 218 
VQoL_Child and 39-item VQoL_Young Person extensions were pre-piloted.  219 
Phase 3: Pre-piloting 220 
The participation rates were 44.1 % and 31.1% for children and young people respectively.  221 
Median completion time was 15 minutes (IQR=13) for children and 10 minutes (IQR=23.75) 222 
for young people, with 86% and 95% of children and young people respectively rating 223 
instrument completion as easy/very easy, and 95% and 100% respectively rating the 224 
instructions as easy/very easy.  225 
Data from one child were excluded due to 76% missing data. There were no missing 226 
responses in the child dataset and a small (≤10.26%) number of missing values per item in 227 
the young people’s dataset.  228 
The number of items with over 50% of responses or 0% responses in an ‘end’ category were 229 
8 and 4 respectively in the child and 5 and 13 in the young person dataset. Items with 230 
problematic distribution were flagged for potential removal during formal piloting of the 30-231 
item VQoL_Child and 39-item VQoL_Young Person.  232 
Phase 4: Piloting 233 




Missing data per item (completely at random) was <3% for both instrument versions. Two 235 
children (but no young people) were excluded from subsequent analysis based on having 236 
>25% missing data per person. All remaining missing data per person was found to be 237 
missing completely at random (MCAR),30 and retained for Rasch analyses.31   238 
Psychometric evaluation 239 
Six items were removed from the VQoL_Child and 5 from the VQoL_Young Person due to 240 
significant skewness, and ceiling effects and a further 4 and 12 respectively during Rasch 241 
based on goodness-of-fit, response ordering and DIF statistics (Table 4, available at 242 
www.aaojournal.org). The resulting 20-item child and 22-item young person instrument 243 
versions showed these statistics to be within acceptable limits. One item fell just outside the 244 
acceptable criteria for only goodness-of-fit criterion but was retained in the VQoL_Young 245 
Person to preserve content validity and comparability with VQol_Child where it was retained 246 
(Table 2). For each version, the item probability plots showed good ordering, and acceptable 247 
differentiation between the 4 response categories (Figure 1) and targeting of items to 248 
respondents (the difference between person and item means = 0.81 logits (child version) and 249 
0.76 (young person version)) although items were clustered around the mid-low end of the 250 
item difficulty scale (Figure 2). Each version showed good precision as indicated by indices 251 
for person separation (3.64 and 2.74 for child and young person versions respectively).17,32 252 
The final 20 item VQoL_Child and 22 item VQoL_Young Person scales included 12 common 253 
‘core’ items and 8 and 10 age specific items respectfully. 254 
Calibration of the VQoL_Child and VQol_Young Person instrument versions 255 
DIF analysis of overlapping core items showed no contrasts greater than 1 logit (Table 2), 256 
demonstrating they were not biased to either age group (after adjusting for the overall scores 257 
of respondents). Thus, all remaining overlapping items are productive for measurement of 258 




Score-to-measure transformation 260 
To enable easy and precise scoring, we developed conversion tables for transforming the 261 
summary scores to Rasch person measures as shown in Table 5 (available at 262 
www.aaojournal.org). These can be used to compare Rasch person measures when using 263 
either or both versions cross-sectionally or sequentially.  264 
Construct validity 265 
We excluded 6 children and 5 young people with missing data before analysing construct 266 
validity. Rasch person measures on the VQoL_Child and VQoL_Young Person correlated 267 
positively with Child and Teen PedsQL scores, substantiating the instrument’s construct 268 
(convergent) validity (Table 3). As anticipated, acuity did not correlate significantly with 269 
VQoL. 270 
DISCUSSION 271 
We report an effective, efficient and child/young person-centred approach to developing an 272 
age-appropriate PROM for children and young people with VI. Using a novel approach for 273 
calibrating instruments and exploiting our prior research and original instrument for those 274 
aged 10-15 years,13,14 we have generated two psychometrically robust versions of this 275 
measure that are suitable for a wider age-range, spanning 8-17 years, whilst retaining 276 
developmentally appropriate content through a modular structure of common core items 277 
alongside age-group specific items. Using this approach, we have improved feasibility for 278 
both patients and clinicians. Our final 20- and 22-item VQoL_Child and VQoL_Young Person 279 
instrument versions, respectively, are shorter than our original version for 10-15 year olds 280 
and reported to be easy to complete without sacrificing comprehensiveness. We have 281 
calibrated the two age-specific versions using overlapping core items, so that the correct 282 
instrument version can be used based on the age of children in the study at that time point 283 
and also so that VQoL can be measured without loss of continuity of measurement as the 284 




used both cross-sectionally (e.g. in trials with a wide age-range of subjects) and sequentially 286 
(e.g. in cohort studies or clinical follow up of individual patients) in future studies and 287 
research. Our log transformation tables, which convert summary scores into Rasch person 288 
measures, provide clinicians the means for using and interpreting scores with precision and 289 
ease. We also provide the model-based standard error of each measure, which should be 290 
used in future clinical research implementing the instruments.  291 
Our two new instrument versions (like the original VQoL_CYP13,14), show good construct 292 
validity, correlating strongly with HRQoL on a generic measure (particularly its psychosocial 293 
component). As anticipated,14 the VQoL scores for both children and young people were not 294 
associated with visual acuity. These findings align with the ‘disability paradox’.28,33,34 This 295 
phenomenon, whereby individuals with severe disabilities or illnesses report good QoL, 296 
exemplifies the importance of considering QoL to be a subjective construct.35 Thus the child 297 
or young person with VI will construct his/her perception of their QoL from the subjective day-298 
to-day experience of living with a visual disability and ultimately, their scores on a self-299 
reported QoL measure will reflect this. This has important implications for how the 300 
VQoL_Child and VQoL_Young Person, and indeed any child QoL PROMs, should be used. 301 
For instance, in the context of trials of new interventions or therapies intended to improve 302 
vision, the implications of the ‘disability paradox’ must be recognised to avoid conclusions 303 
about impact of interventions being misconstrued.  304 
Although the new VQoL instrument versions are age-group specific (for example, concerns 305 
about independent living in the future feature only in the VQoL_Young Person) the significant 306 
overlap in common content across the two versions, as well as with our original 307 
VQoL_CYP,13,14 demonstrates the core life trajectory of children with VI whereby concerns 308 
(e.g. social inclusion and acceptance) and barriers (e.g. in education) emerge and establish 309 
across childhood and adolescence. This is likely to be true also for other child populations. 310 
Moreover, issues related to VI align with other disabilities as well as other chronic complex 311 




the significant correlations with the PedsQL in our study, thereby affirming the strong content 313 
and construct validity of the VQoL_Child and VQoL_Young Person. 314 
Although we achieved a good sized sample relative to the rarity of childhood VI, a more 315 
granular examination of the underlying domain structure in the instrument was not possible 316 
due to limited power. We followed the conventional approach of using infit and outfit statistics 317 
to remove items until all the stringent criteria have been met.17 Unidimensionality, for each 318 
instrument version was sufficiently evidenced by the ranges of infit and outfit statistics which 319 
support the derivation of a summary score, and the scale items span the spectrum of aspects 320 
of QoL suggested by broader literature, 2,35 demonstrating good face validity.  321 
Recognising the lack of instruments suitable for the youngest children with VI and cognisant 322 
that some children can self-report reliably from as young as 5 years,12,36,37 we conducted 323 
some semi-structured and cognitive interviews with children younger than 8 years but found 324 
both recruitment and information capture challenging despite using different child-appropriate 325 
methods. This highlights an important direction for future research. In the meantime, the age-326 
range served by our instrument coincides with that recommended and reported in the 327 
literature,12,16 and enables complementary use of generic HRQoL instruments.  328 
We found both the VQoL_Child and VQoL_Young Person to be somewhat better targeted to 329 
participants reporting lower VQoL. This is comparable to the targeting pattern we reported for 330 
our original instrument for 10-15 year olds14 as well as that reported in the development of 331 
IVI_C,8 which is a similar instrument developed in Australia to assess VQoL of children and 332 
young people with VI. Given that the items seem more suited to children with lower VQoL, 333 
these instruments may be particularly useful in assessing VQoL changes in visually impaired 334 
children and young people who are at risk of lower QoL, for instance, due to receiving less 335 
professional support (e.g. in education) and in the context of relevant interventions aimed at 336 




DIF analyses can be unstable and produce spurious results when applied to small samples. 338 
In particular, they often reflect an increased chance of false positive findings (i.e. removal of 339 
too many items).38 In the case of questionnaire development, this means that a shorter scale 340 
will be produced. This is not the case for the reduced VQoL_Child and VQoL_Young Person 341 
instrument versions which have a good coverage of all elements of VQoL.  342 
Ethical and practical considerations involved in re-testing participants precluded examination 343 
of test-retest reliability and responsiveness of the measure over time. We will address this in 344 
our planned research on optimal approaches to routine implementation of vision PROMs in 345 
clinical practice, to assess how our VQoL instrument can best be deployed alongside our 346 
other vision PROM assessing functional vision39 to enable a holistic assessment of impact 347 
and thus truly ‘personalised’ care.  348 
It is challenging but possible to generate psychometrically robust and developmentally 349 
appropriate instruments usable by the whole age-range of children and young people with VI. 350 
Our novel approach for vision specific PROMs enables a measurement model in which 351 
instruments can be used cross-sectionally and sequentially in both clinical practice and 352 
research. We suggest the approach we have described is transferable to other childhood 353 
ophthalmic conditions and is a parsimonious approach useful in research on rare conditions. 354 
Small sample sizes, inherent in research on rare paediatric populations such as children and 355 
young people with VI can preclude concurrent de novo development of age-group specific 356 
measures. We have overcome the challenges posed by limited sample sizes by starting with 357 
a foundation instrument that is anchored to the middle of the overall age-range (10-15 358 




Figure 1: Category probability curves showing the probability of selecting response 360 
categories across the scale of item difficulty for age-appropriate extensions of the 361 
VQoL_CYP40 362 
Figure 1a: Category probability curves for the 20-item VQoL_Child 363 
Figure 1b: Category probability curves for the 22-item VQoL_Young Person 364 
 365 
Figure 2: Item-person maps illustrating acceptable targeting of VQoL items (located on the 366 
right side of the dashed line) to responders (located on the left side of the dashed line and 367 
represented by X).32 Participants with higher VQoL and items with higher difficulty to endorse 368 
as true are at the top half of the map. 369 
Figure 2a: Item-Person map for the VQoL_Child 370 
Figure 2b: Item-Person map for the VQoL_Young Person 371 
M = mean; S = 1 standard deviation from the mean; T = 2 standard deviations from the 372 
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Table 1. Demographic and clinical characteristics of participants in each phase of VQoL_CYP instrument adaptation. 




(n = 12) 
Young People 
(n = 17) 
Children 
(n = 12) 
Young People 
(n = 16) 
Children 
(n = 26*) 
Young People 
(n = 23) 
Children 
(n = 87**) 
Young People 
(n = 73***) 
Age 
6 1 (8.3) - - - - - - - 
7 - - 2 (16.7) - - - 3 (3.45) - 
8 4 (33.3) - 6 (50) - 3 (11.54) - 19 (21.84) - 
9 7 (58.3) - 3 (25) - 4 (15.38) - 22 (25.29) - 
10 - - 1 (8.3) - 6 (23.08) - 9 (10.34) - 
11 - - - - 8 (30.77) - 16 (18.39) - 
12 - - - - 5 (19.23) - 17 (19.54) - 
13 - - - 3 (18.75)  4 (17.39) 1 (1.15) 8 (10.96) 
14 - - - 2 (12.5)  6 (26.09) - 19 (26.03) 
15 - - - 3 (18.75)  4 (17.39) - 15 (20.55) 
16 - 7 (41.18) - 2 (12.5)  4 (17.39) - 14 (19.18) 
17 - 8 (47.06) - 3 (18.75)  5 (21.74) - 15 (20.55) 
18 - 1 (5.88) - 3 (18.75)  - - 2 (2.74) 
19 - 1 (5.88) - -  - - - 
Gender 
Male 8 (66.7) 10 (58.82) 8 (66.7) 8 (50) 16 (61.54) 13 (56.52) 36 (41.38) 39 (53.42) 
Female 4 (33.3) 7 (41.18) 4 (33.3) 8 (50) 10 (38.46) 10 (43.48) 51 (58.62) 34 (46.58) 
Ethnicity 
White UK majority 
(White British) 
8 (66.7) 10 (58.82) 5 (41.7) 11 (68.75) 13 (50) 16 (69.57) 49 (56.32) 46 (63.01) 
White other (e.g. 
African, Polish, 
Turkish) 
- 1 (5.88) 2 (16.7) 1 (6.25) 4 (15.4) 3 (13.04) 5 (5.75) 4 (5.48) 
Black (British, African, 
Caribbean) 
1 (8.3) - 1 (8.3) - - - 9 (10.34) 3 (4.11) 
Asian (Indian, 
Bangladeshi, Pakistani) 
2 (16.7) 3 (17.65) 2 (16.7) 4 (25) 7 (26.9) 4 (17.39) 18 (20.69) 8 (10.96) 
Asian other (Arabic) - 1 (5.88) - - - - 3 (3.45) 2 (2.74) 
Chinese - - - - - - -  - 
Mixed 1 (8.3) 2 (11.76) 2 (16.7) - - - 3 (3.45) 2 (2.74) 
Missing - - - - 2 (7.7) - - 8 (10.96) 
Severity of visual impairment 
LV: logMAR ≤0.46 - 1 (5.88) - - - - 5 (5.75) 1 (1.37) 
VI1: logMAR 0.48-0.70 4 (33.3) 8 (47.06) 4 (33.3) 9 (56.25) 13 (50) 9 (39.13) 37 (42.53) 20 (27.4) 
VI2: logMAR 0.72-1.00 5 (41.7) 3 (17.65) 3 (25) 5 (31.25) 8 (30.8) 7 (30.43) 32 (36.78) 30 (41.1) 
SVI: logMAR 1.02-1.30 - 2 (11.76) 1 (8.3) 1 (6.25) 3 (11.5) 4 (17.39) 5 (5.75) 8 (10.96) 
Table 1
Blind: logMAR ≥1.32 3 (25) 3 (17.65) 4 (33.3) 1 (6.25) 2 (7.7) 3 (13.04) 8 (9.2) 14 (19.18) 
Timing of onset of visual impairment 
Early (≤2 years) 12 (100) 15 (88.24) 12 (100) 10 (62.5) 25 (96.1) 21 (91.3) 74 (85.06) 58 (79.45) 
Late - 2 (11.76) - 6 (37.5) 1 (3.9) 2 (8.7) 13 (14.94) 15 (20.55) 
Nature of deterioration of visual impairment 
Stable 9 (75) 12 (70.59) 6 (50) 5 (31.25) 18 (69.2) 21 (91.3) 56 (64.37) 60 (82.19) 
Progressive 3 (25) 5 (29.41) 6 (50) 11 (68.75) 8 (30.8) 2 (8.7) 31 (35.63) 13 (17.81) 
Diagnosis by site of visual impairment† 
Whole globe and 
anterior segment 
- 1(5.88) 1 (8.3) 1 (6.25) - - 2 (2.3) 3 (4.11) 
Glaucoma, primary or 
secondary 
1 (8.3) - 3 (25) - 5 (19.23) - 5 (5.75) 10 (13.7) 
Cornea (sclerocornea 
and corneal opacities) 
- - -  1 (6.25) 1 (3.85) 1 (4.35) 1 (1.15) 2 (2.74) 
Lens (cataract and 
aphakia) 
1 (8.3) - 1 (8.3) 2 (12.5) 3 (11.54) 1 (4.35) 11 (12.64) 8 (10.96) 
Uvea - - - - 2 (7.69) 1 (4.35) 4 (4.6) 7 (9.59) 
Retina 9 (75) 12 (70.59) 8 (66.67) 9 (56.25) 15 (57.69) 18 (78.26) 56 (64.37) 50 (68.49) 
Optic nerve 1 (8.3) 3 (17.65) 1 (8.3) 3 (18.75) 1 (3.85) 2 (8.7) 12 (13.79) 4 (5.48) 
Cerebral/visual 
pathways 




- 6 (35.29) 1 (8.3) - 3 (11.54) 3 (13.04) 16 (18.39) 13 (17.81) 
Index of multiple deprivation quintile rank 
1: most deprived 2 (16.7) 1 (5.88) 1 (8.3) 2 (12.5) 1 (3.8) 1 (4.35) 21 (24.14) 17 (23.29) 
2 1 (8.3) 2 (11.76) 5 (41.7) - 9 (34.6) 5 (21.74) 14 (16.09) 14 (19.18) 
3 3 (25) 4 (23.53) 2 (16.7) 4 (25) 8 (30.8) 4 (17.39) 17 (19.54) 11 (15.07) 
4 2 (16.7) 8 (47.06) 3 (25) 3 (18.75) 4 (15.4) 5 (21.74) 15 (17.24) 12 (16.44) 
5: least deprived 4 (33.3) 2 (11.76) 1 (8.3) 7 (43.75) 4 (15.4) 8 (34.78) 17 (19.54) 19 (26.03) 
Missing - - -  - - - 3 (3.45)**** - 
 
*One child excluded from analysis due to incomplete child data (child having learning difficulties and parent proxy data provided instead).  
**Four children excluded from analysis due to incomplete (n= 2, more than 25% data missing) or completely missing (n=2) child data (e.g. parent proxy report provided 
instead). 
***Two young people excluded from analysis due to completely missing (n=1) young person data (e.g. parent proxy report provided instead) and failure to consent (n=1) to 
use of young person data. 
****Data missing due to postcode data not provided by the managing clinical team, as per local governance approval at the patient identification centre. 
† Does not add up to 100% because some children had visual impairment originating in multiple sites. 
 
 
Table 2. Rasch fit statistics, item measure and differential item functioning (DIF) contrasts for the 20-item and 22 item age-appropriate VQoL instrument 





















































































































































































































I make new friends 
easily 
I make new friends 
easily 
0.44 0.98 0.96 -0.27 -0.16 0.47 0.91 0.86 -0.75 0.41  .25 
I keep friends 
easily 
I keep friends 
easily 
-0.39 0.84 0.83 0.1 -0.11 -0.52 0.81 0.96 0 0.22  -.27 
  I am happy with my 
social life 
          -0.25 0.89 0.83 0.44 -0.29   
  I spend enough time 
with my friends 
          0.06 1.19 1.13 0.48 0.16   
Other children pick 
on me because of 
my eyesight 
  -0.3 1.04 1.02 0.57 0.49             
I can stand up for 
myself if someone 
picks on me 
  0.01 1.28 1.24 -0.12 0.23             
My friends 
understand how 
things are for me 
because of my 
eyesight 
  -0.29 1.04 1.1 0.22 0.2             
Table 2
  I get treated the 
same as everyone 
else 
          -0.22 1.18 1.19 -0.59 -0.1   
  I feel like I fit in           -0.25 1.01 0.9 0.08 -0.4   
My friends 
encourage me to 
join in their 
activities 
My friends 
encourage me to 
join in their 
activities 
0.26 1.28 1.45 0 0.42 -0.51 1.02 0.94 0 -0.18  -.29 
I feel different from 
other children 
because of my 
eyesight 
I feel different from 
other young people 
because of my 
eyesight 
0.94 0.95 0.97 0.11 0.22 0.62 0.97 0.98 0.27 -0.57  -.16 
I feel left out 
because of my 
eyesight 
I feel left out 
because of my 
eyesight 
-0.08 0.65 0.62 -0.08 0.09 -0.5 1.01 0.89 0.34 -0.33  -.14 
I can decide things 
for myself 
  -0.78 1 1.2 0.77 0.24             
I am independent 
at home 
I am independent 
at home 
-0.44 0.94 0.95 0.14 0.17 -0.37 1.07 1.12 -0.1 -0.19  .00 
I am independent 
at school 
I am independent 
at school/college 
-0.11 0.94 0.94 0 0.27 -0.03 0.8 0.83 0.06 0.22  -.11 
  I can do most 
activities on my own 
          0.19 1 0.95 -0.18 0.54   
People give me a 
chance to do things 
for myself 
  -0.34 0.79 0.76 0.21 -0.1             
I am happy asking 
for help 
I am comfortable 
asking for help 
-0.52 1.13 1.02 -0.54 -0.11 -0.02 1.03 1.06 0.06 0.2  .06 
I cope well with my 
eyesight problems 
I cope well with my 
eyesight problems 
-0.74 1.02 0.97 -0.7 -0.79 -0.49 0.89 0.83 -0.16 -0.22  .06 
I feel tired because 
of my eyesight 
0.74 1.28 1.35 0.39 -0.52
I feel frustrated 
because of my 
eyesight 
I feel frustrated 
because of my 
eyesight 
0.51 0.96 1.05 0 -0.09 0.78 1.38 1.53 -0.06 -0.07  .00
I feel confident 0.27 0.74 0.75 0 0.5 
Other people are fair 
to me 
-0.13 0.67 0.65 0.05 0 
I worry what other 
people think of me 
because of my 
eyesight 
I worry what other 
people think of me 
because of my 
eyesight 
0.25 1.16 1.23 -0.53 0.17 0.45 1.13 1.02 -0.28 0.26  .00 
I am positive about 
the future 
0.08 0.91 0.96 0 -0.11
I am confident I will 
be able to look after 
myself in the future 
-0.03 0.93 0.83 -0.03 0 
I worry about what 
job I will be able to 
do in the future 
0.62 0.96 0.96 -0.03 0.53 
I like to have a go at 
everything 
-0.19 0.95 0.88 0.46 -0.27




-0.37 0.99 0.94 -0.33 -0.36 -0.16 1.19 1.21 0.06 -0.67  -.02
I have to work 
harder at school 
because of my 
eyesight 
1.34 1.09 1.12 0 -0.33
*MNSQ = Mean square standardized residual within the pre-defined interval (0.5, 1.5)17 **DIF = Differential item functioning within a 1 logit threshold24, 27
 
Table 3: Construct validity of VQoL_Child and VQoL_Young Person** 
 VQoL_Child VQoL_ 
Young Person 
Scores from the VQoL_Child and VQoL_Young 
Person combined (representing the calibrated 
collection of instruments). 









































*Spearman’s Rank Coefficient r (p values) 
** All observed correlations are within the pre-defined threshold.17 
Table 3
Table 4. Item reduction in Phase 4  
Items removed – VQoL_Child Items removed – VQoL_Young Person 
Item Removal criteria Item Removal criteria 
I have got some 
good friends 
Item distribution I have got some 
good friends 
Item distribution 
I am happy with 
how many friends I 
have 
Item distribution   
I spend enough 
time with my 
friends 
Rasch  
- removed due to 
ordering of person 
abilities and 
response scales 
(not in the right 
order) 
  
  Other young 
people my age 
pick on me 
because of my 
eyesight 
Rasch 
- removed because 
of DIF* by gender 
(more difficult for 
females to endorse 
as true) 
  I can stand up for 
myself if someone 
picks on me 
Rasch 
- removed because 
of DIF by age (more 
difficult for older age 
group to endorse as 
true) 
  My friends 
understand how 
things are for me 
because of my 
eyesight 
Rasch 
- removed due to 
item fit (OUTFIT 
MNSQ** = 1.56) 
My friends help me 
at school 
Rasch 
- removed due to 
item fit (OUTFIT 
MNSQ = 1.74) 
My friends help me 




things are for me 
because of my 
eyesight 
Item distribution My teachers and 
tutors understand 
how things are for 
me because of my 
eyesight 
Rasch 
- removed due to 
item fit (OUTFIT 
MNSQ = 2.23) 
I get along with my 
family 
Item distribution  Item distribution 
  I am comfortable 
going places on 
my own 
Rasch 
- removed because 
of DIF by gender 
(more difficult for 
females to endorse 
as true) 
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Table 4. Item reduction in Phase 4  
Items removed – VQoL_Child Items removed – VQoL_Young Person 
Item Removal criteria Item Removal criteria 
  People give me a 
chance to do 
things on my own 
Rasch 
- removed because 
of ordering of person 
abilities and 
response scales (not 
in the right order) 
  People overprotect 
me because of my 
eyesight 
Rasch 
- removed due to 
item fit (OUTFIT 
MNSQ = 2.23) 
  I have enough 
private time to 
myself 
Item distribution 
  I feel tired because 
of my eyesight 
Rasch 
- removed due to 
item fit (OUTFIT 
MSQ = 1.62) and 
ordering of person 
abilities and 
response scales (not 
in the right order) 
I feel lonely 
because of my 
eyesight 
Item distribution I feel lonely 
because of my 
eyesight 
Item distribution 
I feel confident Rasch 
- removed due to 
ordering of person 
abilities and 
response scales 
(not in the right 
order) 
  
  I am treated fairly 
by my friends 
Rasch 
- removed because 
of ordering of person 
abilities and 
response scales (not 
in the right order) 





Item distribution   
I can do most 
activities on my 
own 
Rasch 
- removed due to 
ordering of person 
abilities and 
  
Table 4. Item reduction in Phase 4 
Items removed – VQoL_Child Items removed – VQoL_Young Person 
Item Removal criteria Item Removal criteria 
response scales 
(not in the right 
order) 
I worry my 
eyesight will get 
worse 
Rasch 
- removed due to
item fit (OUTFIT
MNSQ = 1.53)
I can get around 
on my own 
Rasch 
- removed because




I have to work 
harder at 
school/college 
because of my 
eyesight 
Rasch 
- removed due to
item fit (OUTFIT
MNSQ = 1.59)
*DIF = Differential item functioning
**MNSQ = Mean squared standardized residuals
Table 5a. Conversion table for transforming raw scores on the 20-item VQoL_Child into 
comparable Rasch person measures. 
Score Measure S.E. Score Measure S.E. Score Measure S.E.
0 0.00 16.92 21 44.19 2.57 42 58.41 2.64 
1 11.26 9.34 22 44.90 2.55 43 59.17 2.69 
2 17.88 6.68 23 45.59 2.52 44 59.97 2.73 
3 21.84 5.52 24 46.28 2.50 45 60.80 2.79 
4 24.71 4.83 25 46.95 2.49 46 61.66 2.85 
5 26.99 4.37 26 47.62 2.47 47 62.56 2.93 
6 28.90 4.04 27 48.28 2.46 48 63.52 3.01 
7 30.55 3.78 28 48.94 2.46 49 64.53 3.11 
8 32.01 3.58 29 49.59 2.45 50 65.62 3.23 
9 33.33 3.41 30 50.24 2.45 51 66.80 3.37 
10 34.54 3.27 31 50.89 2.45 52 68.09 3.54 
11 35.66 3.16 32 51.54 2.45 53 69.52 3.75 
12 36.70 3.06 33 52.19 2.46 54 71.15 4.01 
13 37.68 2.97 34 52.84 2.46 55 73.03 4.35 
14 38.61 2.90 35 53.50 2.47 56 75.30 4.82 
15 39.50 2.83 36 54.17 2.49 57 78.16 5.51 
16 40.35 2.77 37 54.84 2.50 58 82.11 6.68 
17 41.17 2.72 38 55.53 2.52 59 88.73 9.34 
18 41.96 2.68 39 56.22 2.55 60 100.00 16.92 
19 42.72 2.64 40 56.93 2.57 
20 43.46 2.60 41 57.99 2.61 
*scores ranging from 1-4 must be re-scored into a scale of 0-3 (and negative items reversed)
before conversion.
Supplemental Table 5 (online only)
Table 5b. Conversion table for transforming raw scores on the 22-item VQoL_Young Person into 
comparable Rasch person measures. 
Score Measure S.E. Score Measure S.E. Score Measure S.E.
0 0.00 16.39 23 41.91 2.34 46 56.31 2.59 
1 10.82 8.99 24 42.52 2.33 47 57.08 2.63 
2 17.08 6.38 25 43.12 2.32 48 57.86 2.68 
3 20.77 5.23 26 43.72 2.31 49 58.68 2.73 
4 23.41 4.55 27 44.31 2.30 50 59.52 2.78 
5 25.48 4.10 28 44.90 2.30 51 60.40 2.84 
6 27.20 3.77 29 45.49 2.29 52 61.33 2.91 
7 28.68 3.52 30 46.07 2.30 53 62.30 2.99 
8 29.98 3.32 31 46.66 2.30 54 63.32 3.07 
9 31.14 3.16 32 47.25 2.30 55 64.41 3.17 
10 32.21 3.02 33 47.84 2.31 56 65.57 3.29 
11 33.19 2.91 34 48.44 2.32 57 66.82 3.42 
12 34.10 2.82 35 49.04 2.33 58 68.18 3.58 
13 34.96 2.74 36 49.65 2.34 59 69.69 3.78 
14 35.78 2.67 37 50.26 2.35 60 71.38 4.02 
15 36.55 2.61 38 50.88 2.37 61 73.32 4.34 
16 37.29 2.56 39 51.51 2.39 62 75.63 4.78 
17 38.01 2.51 40 52.15 2.41 63 78.52 5.44 
18 38.70 2.47 41 52.81 2.43 64 82.49 6.56 
19 39.37 2.44 42 53.48 2.46 65 88.98 9.12 
20 40.03 2.41 43 54.16 2.49 66 100.00 16.47 
21 40.67 2.38 44 54.86 2.52 
22 41.30 2.36 45 55.58 2.56 
*scores ranging from 1-4 must be re-scored into a scale of 0-3 (and negative items reversed)
before conversion.
